Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

被引：4
|
作者：
Kim, Young-Hak [1 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 380卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：989 / 990
页数：2
相关论文
共 50 条
  • [31] Uptake and outcomes of adjuvant durvalumab following concurrent chemoradiotherapy in unresected stage 3 non-small-cell lung cancer
    Mason, Holly
    Jain, Pooja
    Sun Fei
    Teo, Mark
    Franks, Kevin
    Clarke, Katy
    LUNG CANCER, 2021, 156 : S41 - S41
  • [32] Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study
    Hui, Rina
    Ozguroglu, Mustafa
    Villegas, Augusto
    Daniel, Davey
    Vicente, David
    Murakami, Shuji
    Yokoi, Takashi
    Chiappori, Alberto
    Lee, Ki Hyeong
    de Wit, Maike
    Cho, Byoung Chul
    Gray, Jhanelle E.
    Ryden, Anna
    Viviers, Louis
    Poole, Lynne
    Zhang, Yiduo
    Dennis, Phillip A.
    Antonia, Scott J.
    LANCET ONCOLOGY, 2019, 20 (12): : 1670 - 1680
  • [33] Surgery in stage III non-small-cell lung cancer
    Eberhardt, Wilfried E. E.
    Stamatis, Georgios
    Stuschke, Martin
    LANCET, 2009, 374 (9687): : 359 - 360
  • [34] Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity
    Phernambucq, E. C. J.
    Spoelstra, F. O. B.
    Verbakel, W. F. A. R.
    Postmus, P. E.
    Melissant, C. F.
    van den Brink, K. I. Maassen
    Frings, V.
    van de Ven, P. M.
    Smit, E. F.
    Senan, S.
    ANNALS OF ONCOLOGY, 2011, 22 (01) : 132 - 138
  • [35] Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer
    Rice, TW
    Adelstein, DJ
    Ciezki, JP
    Becker, ME
    Rybicki, LA
    Farver, CF
    Larto, MA
    Blackstone, EH
    ANNALS OF THORACIC SURGERY, 1998, 66 (06): : 1909 - 1914
  • [36] Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer
    Phernambucq, Erik C. J.
    Spoelstra, Femke O. B.
    Paul, Marinus A.
    Senan, Suresh
    Melissant, Christian F.
    Postmus, Pieter E.
    Smit, Egbert F.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (06) : 1052 - 1057
  • [37] Should Older Patients with Stage Iii Non-small-Cell Lung Cancer Be Treated with Concurrent Chemoradiotherapy?
    Wallace, N. D.
    Alexander, M.
    Xie, S.
    Ball, D.
    Solomon, B.
    Plumridge, N.
    Shaw, M.
    Harden, S.
    Hegi-Johnson, F.
    Siva, S.
    John, T.
    Officer, A.
    MacManus, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S289 - S290
  • [38] Durvalumab after chemo-radiotherapy in stage III non-small cell lung cancer
    Chiramel, Jaseela
    Tay, Rebecca
    Califano, Raffaele
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S991 - S994
  • [39] Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non-small-cell lung cancer (NEJ056)
    Furuta, Megumi
    Horinouchi, Hidehito
    Yokota, Isao
    Yamaguchi, Teppei
    Itoh, Shoichi
    Fukui, Takafumi
    Iwashima, Akira
    Sugisaka, Jun
    Miura, Yu
    Tanaka, Hisashi
    Miyawaki, Taichi
    Yokouchi, Hiroshi
    Miura, Keita
    Saito, Ryota
    Saito, Go
    Kamoshida, Tatsuhiko
    Uchinami, Yusuke
    Kato, Tatsuya
    Kobayashi, Kunihiko
    Asahina, Hajime
    CANCER SCIENCE, 2024,
  • [40] Durvalumab showed long and durable effects after chemoradiotherapy in stage III non-small cell lung cancer: results of the PACIFIC study
    Uemura, Takehiro
    Hida, Toyoaki
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1108 - S1112
12345